Dr Olivia Nunez Iway, MD in Elkhart, KS - Psychiatry & Neurology

Dr Olivia Nunez Iway, MD is a Psychiatry & Neurology - Psychiatry physician based in Elkhart, Kansas. Dr Olivia Nunez Iway is licensed to practice in Kansas (license number 04-18798) and her current practice location is 411 Sunset Dr., Elkhart, Kansas. She can be reached at her office (for appointments etc.) via phone at (620) 697-2175.

NPI number for Dr Olivia Nunez Iway is 1639176969 and her current mailing address is 411 Sunset Drive, Elkhart, Kansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1639176969.

Contact Information

	Dr Olivia Nunez Iway, MD
	411 Sunset Dr., Elkhart, KS 67950
	(620) 697-2175
	(620) 697-2185

Physician's Profile

Full Name	Dr Olivia Nunez Iway
Gender	Female
Speciality	Psychiatry & Neurology - Psychiatry
Location	411 Sunset Dr., Elkhart, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1639176969
Provider Enumeration Date: 07/01/2005
Last Update Date: 06/07/2011

Medical Identifiers

Medical identifiers for Dr Olivia Nunez Iway such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1639176969	NPI	-	NPPES
100155330A	Medicaid	KS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	04-18798 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Olivia Nunez Iway is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Olivia Nunez Iway, MD 411 Sunset Drive, Elkhart, KS 67950 Ph: (620) 697-2175	Dr Olivia Nunez Iway, MD 411 Sunset Dr., Elkhart, KS 67950 Ph: (620) 697-2175

News Archive

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

Low-dose hormone therapy may be effective in easing sleep issues for recently menopausal women

For many women, the side effects of menopause don't call it a day when they do. Between 40 and 60 percent of women in perimenopause and early menopause face issues with sleep because of this physical change. The majority also report hot flashes and night sweats, which can be disruptive to falling and staying asleep.

Mindfulness meditation training helps prevent major depression

Among primary care patients with subthreshold depression, mindfulness meditation training reduces the incidence of major depression and improves depression symptoms.

Ekkyo publishes positive results from its LASH treatment study

A Multi-Center Clinical Study Started in 2007 Confirms That the Results of Physiological Scarring After Surgery can be Improved by Using the LASH(R) (Laser Assisted Skin Healing) Treatment. This New Therapeutic Approach is Based on the EkkyLite(TM) System and is the First Device to Improve Scarring. it has been Developed and is Sold by Ekkyo.

Dr Olivia Nunez Iway, MD - Psychiatry & Neurology in Elkhart, KS